Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have emerged as a revolutionary class of drugs with far-reaching protective effects in multiple organs. The protective potential of SGLT2i is much broader than that of the classical concept of glucose control and consists of an entire conglomerate o...

Full description

Bibliographic Details

Main Authors:	A. A. Avagimyan, M. Sheibani, A. I. Trofimenko, E. E. Lysov, F. M. Khamidova, A. Z. Aznauryan, L. M. Sukiasyan, K. T. Sahakyan, T. R. Gevorgyan, M. R. Tatoyan, G. L. Mkrtchyan, G. L. Meltonyan, A. R. Petrosyan, L. A. Martemyanova, R. R. Petrosyan, O. I. Urazova, N. V. Pogosova, N. Sarrafzadegan
Format:	Artigo
Language:	Inglês
Published:	Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1 2024-11-01
Series:	Инновационная медицина Кубани
Subjects:	sglt2i cardioprotection nephroprotection dapagliflozin empagliflozin
Online Access:	https://www.innovmedkub.ru/jour/article/view/979
Tags:	Add Tag No Tags, Be the first to tag this record!